173 related articles for article (PubMed ID: 37184660)
1. Diagnostic and prognostic performance of plasma neurofilament light chain in multiple system atrophy: a cross-sectional and longitudinal study.
Peng L; Wan L; Liu M; Long Z; Chen D; Yuan X; Tang Z; Fu Y; Zhu S; Lei L; Wang C; Peng H; Shi Y; He L; Yuan H; Wan N; Hou X; Xia K; Li J; Chen C; Qiu R; Tang B; Chen Z; Jiang H
J Neurol; 2023 Sep; 270(9):4248-4261. PubMed ID: 37184660
[TBL] [Abstract][Full Text] [Related]
2. Neurofilament light levels predict clinical progression and death in multiple system atrophy.
Chelban V; Nikram E; Perez-Soriano A; Wilke C; Foubert-Samier A; Vijiaratnam N; Guo T; Jabbari E; Olufodun S; Gonzalez M; Senkevich K; Laurens B; Péran P; Rascol O; Le Traon AP; Todd EG; Costantini AA; Alikhwan S; Tariq A; Ng BL; Muñoz E; Painous C; Compta Y; Junque C; Segura B; Zhelcheska K; Wellington H; Schöls L; Jaunmuktane Z; Kobylecki C; Church A; Hu MTM; Rowe JB; Leigh PN; Massey L; Burn DJ; Pavese N; Foltynie T; Pchelina S; Wood N; Heslegrave AJ; Zetterberg H; Bocchetta M; Rohrer JD; Marti MJ; Synofzik M; Morris HR; Meissner WG; Houlden H
Brain; 2022 Dec; 145(12):4398-4408. PubMed ID: 35903017
[TBL] [Abstract][Full Text] [Related]
3. Neurofilament Light Chain Predicts Disease Severity and Progression in Multiple System Atrophy.
Zhang L; Cao B; Hou Y; Gu X; Wei Q; Ou R; Zhao B; Luo C; Shang H
Mov Disord; 2022 Feb; 37(2):421-426. PubMed ID: 34719813
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid levels of neurofilament light chain in multiple system atrophy relative to Parkinson's disease: a meta-analysis.
Hu X; Yang Y; Gong D
Neurol Sci; 2017 Mar; 38(3):407-414. PubMed ID: 27896490
[TBL] [Abstract][Full Text] [Related]
5. Neurofilament light chain in spinal fluid and plasma in multiple system atrophy: a prospective, longitudinal biomarker study.
Singer W; Schmeichel AM; Sletten DM; Gehrking TL; Gehrking JA; Trejo-Lopez J; Suarez MD; Anderson JK; Bass PH; Lesnick TG; Low PA
Clin Auton Res; 2023 Dec; 33(6):635-645. PubMed ID: 37603107
[TBL] [Abstract][Full Text] [Related]
6. Combination of Plasma Neurofilament Light Chain and Mini-Mental State Examination Score Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease within 5 Years.
Darmanthé N; Tabatabaei-Jafari H; Cherbuin N;
J Alzheimers Dis; 2021; 82(3):951-964. PubMed ID: 34120902
[TBL] [Abstract][Full Text] [Related]
7. Plasma and CSF Neurofilament Light Chain in Amyotrophic Lateral Sclerosis: A Cross-Sectional and Longitudinal Study.
Vacchiano V; Mastrangelo A; Zenesini C; Masullo M; Quadalti C; Avoni P; Polischi B; Cherici A; Capellari S; Salvi F; Liguori R; Parchi P
Front Aging Neurosci; 2021; 13():753242. PubMed ID: 34744694
[No Abstract] [Full Text] [Related]
8. Utility of plasma Neurofilament light as a diagnostic and prognostic biomarker of the postural instability gait disorder motor subtype in early Parkinson's disease.
Ng ASL; Tan YJ; Yong ACW; Saffari SE; Lu Z; Ng EY; Ng SYE; Chia NSY; Choi X; Heng D; Neo S; Xu Z; Keong NCH; Tay KY; Au WL; Tan LCS; Tan EK
Mol Neurodegener; 2020 Jun; 15(1):33. PubMed ID: 32503574
[TBL] [Abstract][Full Text] [Related]
9. Blood NfL: A biomarker for disease severity and progression in Parkinson disease.
Lin CH; Li CH; Yang KC; Lin FJ; Wu CC; Chieh JJ; Chiu MJ
Neurology; 2019 Sep; 93(11):e1104-e1111. PubMed ID: 31420461
[TBL] [Abstract][Full Text] [Related]
10. Neurofilament light chain and α-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes.
Quadalti C; Calandra-Buonaura G; Baiardi S; Mastrangelo A; Rossi M; Zenesini C; Giannini G; Candelise N; Sambati L; Polischi B; Plazzi G; Capellari S; Cortelli P; Parchi P
NPJ Parkinsons Dis; 2021 Oct; 7(1):93. PubMed ID: 34635674
[TBL] [Abstract][Full Text] [Related]
11. Clinical correlations of cerebrospinal fluid biomarkers including neuron-glia 2 and neurofilament light chain in patients with multiple system atrophy.
Tokutake T; Kasuga K; Tsukie T; Ishiguro T; Shimohata T; Onodera O; Ikeuchi T
Parkinsonism Relat Disord; 2022 Sep; 102():30-35. PubMed ID: 35933820
[TBL] [Abstract][Full Text] [Related]
12. Relationship between plasma NFL and disease progression in Parkinson's disease: a prospective cohort study.
Ou R; Liu K; Lin J; Yang T; Xiao Y; Wei Q; Hou Y; Li C; Zhang L; Jiang Z; Zhao B; Chen X; Song W; Wu Y; Shang H
J Neurol; 2024 Apr; 271(4):1837-1843. PubMed ID: 38063869
[TBL] [Abstract][Full Text] [Related]
13. Blood Neurofilament Light in Progressive Multiple Sclerosis: Post Hoc Analysis of 2 Randomized Controlled Trials.
Leppert D; Kropshofer H; Häring DA; Dahlke F; Patil A; Meinert R; Tomic D; Kappos L; Kuhle J
Neurology; 2022 May; 98(21):e2120-e2131. PubMed ID: 35379762
[TBL] [Abstract][Full Text] [Related]
14. Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease.
Aamodt WW; Waligorska T; Shen J; Tropea TF; Siderowf A; Weintraub D; Grossman M; Irwin D; Wolk DA; Xie SX; Trojanowski JQ; Shaw LM; Chen-Plotkin AS
Mov Disord; 2021 Dec; 36(12):2945-2950. PubMed ID: 34480363
[TBL] [Abstract][Full Text] [Related]
15. Quantitative susceptibility mapping and blood neurofilament light chain differentiate between parkinsonian disorders.
Zhang P; Chen J; Cai T; He C; Li Y; Li X; Chen Z; Wang L; Zhang Y
Front Aging Neurosci; 2022; 14():909552. PubMed ID: 35992605
[TBL] [Abstract][Full Text] [Related]
16. Utility of Plasma Neurofilament Light in the 1Florida Alzheimer's Disease Research Center (ADRC).
Barker W; Quinonez C; Greig MT; Behar R; Chirinos C; Rodriguez RA; Rosselli M; Rodriguez MJ; Cid RC; Rundek T; McFarland K; Hanson K; Smith G; DeKosky S; Vaillancourt D; Adjouadi M; Marsiske M; Ertekin-Taner N; Golde T; Loewenstein DA; Duara R
J Alzheimers Dis; 2021; 79(1):59-70. PubMed ID: 33216030
[TBL] [Abstract][Full Text] [Related]
17. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease.
Holmberg B; Rosengren L; Karlsson JE; Johnels B
Mov Disord; 1998 Jan; 13(1):70-7. PubMed ID: 9452329
[TBL] [Abstract][Full Text] [Related]
18. Neurofilament light chain and MRI volume parameters as markers of neurodegeneration in multiple sclerosis.
Filippi P; Vestenická V; Siarnik P; Sivakova M; Čopíková-Cudráková D; Belan V; Hanes J; Novák M; Kollar B; Turcani P
Neuro Endocrinol Lett; 2020 Apr; 41(1):17-26. PubMed ID: 32338853
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic utility of fluid biomarkers in multiple system atrophy: a systematic review and meta-analysis.
Cong S; Xiang C; Wang H; Cong S
J Neurol; 2021 Aug; 268(8):2703-2712. PubMed ID: 32162061
[TBL] [Abstract][Full Text] [Related]
20. Blood neurofilament light chain in Parkinson's disease.
Buhmann C; Magnus T; Choe CU
J Neural Transm (Vienna); 2023 Jun; 130(6):755-762. PubMed ID: 37067597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
